Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    " February 03, 2010":" March 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 03, 2010":" March 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Stocrin Re-examination Study (0831-028)
Condition: HIV Infection
Intervention:
2 Completed A Safety Study of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo
3 Completed Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Condition: HIV Infections
Interventions: Drug: darunavir/ritonavir QD + raltegravir BID;   Drug: darunavir/r QD + tenofovir/emtricitabine QD (fixed dose combination)
4 Completed Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: GSK1349572
5 Terminated Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
6 Unknown  Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
7 Completed HIV Vaccine Study in HIV Positive Patients
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose);   Biological: HIV-v (High Dose);   Biological: HIV-v (Control)
8 Completed Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
Conditions: HIV;   HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
9 Completed Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)
Condition: HIV Infection
Intervention:
10 Completed Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Condition: HIV Infection
Interventions: Biological: AGS-004;   Biological: Placebo
11 Completed Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil fumarate (TDF)
12 Unknown  Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: DOT-HAART
13 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
14 Completed Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
Conditions: HIV-1 Infection;   HIV Infections
Intervention: Biological: PENNVAX-B
15 Completed Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection
Condition: HIV Infection
Intervention: Biological: blood test at day one
16 Completed A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Minocycline
17 Completed
Has Results
Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268)
Condition: HIV-1 Infections
Intervention:
18 Completed
Has Results
Special Investigation of Kaletra in Pregnant Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
19 Completed
Has Results
Drug Use Investigation of Kaletra
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
20 Completed Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza
Condition: HIV
Intervention: Biological: Foceteria® (Novartis)

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.